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Abstract 27 
To evaluate functions of Lactobacillus strains, isolated from fermented food, in restoration of 28 
ampicillin-induced disruption based on mucosal barrier, gut microbial community and 29 
metabolome analyses, three Lactobacillus strains, L. plantarum CGMCC12436 (LacP), L. 30 
casei CGMCC 12435 (LacC) and L. rhamnosus strain GG (LacG) were individually 31 
administered to ampicillin-pretreated mice. All three strains significantly restored 32 
concentrations of endotoxin and diamine oxidase to control levels. Linear discriminate 33 
analysis based on 16S rRNA sequencing of faecal bacteria revealed that the restoration of 34 
microbial communities by Lactobacillus strains was more effective than natural restoration. 35 
Correlation analysis between microbiota and metabolites indicated that, the higher level of 36 
acetate in LacC group was positively correlated with increased relative abundance of 37 
Citrobacter, Bifidobacterium and S24-7. Furthermore, LacC down-regulated the expression of 38 
NF-B p65 and modulated the ampicillin-induced inflammatory responses. The LacC strain 39 
could particularly attenuate ampicillin-induced disruption by optimisation of microbial taxa 40 
and enhancement of acetate and butyrate production. 41 
 42 
Keywords: gut dysbiosis; microbial ecology; metabolites; immunity; functional food 43 
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1 Introduction 45 
The intestinal distal gastrointestinal tract is colonised by trillions of microbes, and this 46 
extensive microbial community comprising approximately 1012 CFU in the colon, influences 47 
gastrointestinal physiology, metabolism, immunity and susceptibility to disease infection 48 
(Lozupone, Stombaugh, Gordon, Jansson, & Knight, 2012). The disruption of the “balanced” 49 
microbiota, referred to as dysbiosis, can drive functional and inflammatory changes in 50 
animals and humans (Petersen & Round, 2014). In the last decade, a large number of studies 51 
have announced significant alterations in the structure of microbial communities in patients 52 
and mice models of dysbiosis-related diseases such as inflammatory bowel diseases, diabetes, 53 
obesity, asthma and autism (Becattini, Taur, & Pamer, 2016; Karlsson et al., 2013). Alterations 54 
to the intestinal microbiota during a critical developmental period also had lasting metabolic 55 
consequences (Abrahamsson et al., 2014; Parracho, Bingham, Gibson, & McCartney, 2005). 56 
Antibiotic-induced dysbiosis was linked to changes in colonic microbial ecology; ampicillin 57 
has been shown to decrease the number of Bifidobacteria, increase Candida, and reduce the 58 
production of short-chain fatty acids (SCFA) (Hawrelak & Myers, 2004; Mangin, Suau, 59 
Gotteland, Brunser, & Pochart, 2010). It was suggested that, due to the inability to 60 
differentiate between commensals and pathogens, antibiotics perturbed the microbiota 61 
structure and the evolutionary relationship between the immune system and the host 62 
symbionts (Aguilera, Cerda-Cuellar, & Martinez, 2015; Buffie et al., 2012; Cho et al., 2012). 63 
Antibiotic use could induce dysregulation of metabolic activities conducted by colonic 64 
microbiota (Lee & Hase, 2014). Microbial metabolites are capable of manipulating the 65 
metabolic integrity of intestinal epithelial cells and causing intestinal immune responses 66 
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(Arpaia & Rudensky, 2014). Some bacterial fermentation products, particularly SCFA, were 67 
considered as key signs of colonic health, but the specific relationship between the microbial 68 
community and metabolites under the status of antibiotic-induced dysbiosis is poorly 69 
understood. The intestinal immune response should be balanced between the tolerance for 70 
unexpected immune molecules and pathogen-induced inflammation in the host cells and 71 
commensal bacteria, with the balance developed by mucus production and antimicrobial 72 
peptides to establish a barrier between host tissue and the microbes (Johansson, Larsson, & 73 
Hansson, 2011; Vaishnava et al., 2011). Toll-like receptors (TLRs) are a group of pattern 74 
recognition receptors, that play a crucial role in mucosal immune response (de Kivit, Tobin, 75 
Forsyth, Keshavarzian, & Landay, 2014) and can recognise microbe-associated molecular 76 
patterns (MAMPs). As one of these MAMPs, lipopolysaccharide (LPS) can be increased 77 
through antibiotic use and cause an innate immune response via TLR4 in intestinal epithelial 78 
cells (Collado-Romero, Arce, Ramirez-Boo, Carvajal, & Garrido, 2010). It is well accepted 79 
that LPS initiates a signalling pathway through TLR4 to activate NF-B, and leads to 80 
inflammation and removal of infection by pro-inflammatory cytokines including TNF-α and 81 
IL-1β (Doyle & O'Neill, 2006). One strain of Lactobacillus has been proven to down-regulate 82 
the expression of pro-inflammatory cytokines in a TLR4-dependent NF-B signal pathway 83 
(Shimazu et al., 2012). 84 
A number of Lactobacillus strains, tested as cocktails or individual strains, were shown to 85 
alleviate gut-related disorders or metabolic diseases such as obesity, diabetes and 86 
non-alcoholic fatty liver disease in mice (Aronsson et al., 2010; Simon et al., 2015; Wang et 87 
al., 2015; Xu, Wan, Fang, Lu, & Cai, 2012; Yoo et al., 2013). Importantly, different probiotic 88 
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strains were proven to have remarkably different abilities to modulate gut metabolism and 89 
immune response (Fåk & Bäckhed, 2012; Million et al., 2012; Yin, Yu, Fu, Liu, & Lu, 2010). 90 
It remains unclear whether specific Lactobacillus strains can be administered to regulate the 91 
alteration of the gut microbiota and subsequently promote the production of beneficial 92 
metabolites. Moreover, it has been reported that a Lactobacillus mixture played a beneficial 93 
role in the immune response in mice through balancing anti- or pro-inflammatory cytokines 94 
(Taranu, Marin, Pistol, Motiu, & Pelinescu, 2015). 95 
In the present study, a model of dysbiosis was constructed by exposing healthy adult mice 96 
to a therapeutic-dose of ampicillin, leading to perturbed gut microbiota. The 97 
ampicillin-induced dysbiosis was confirmed by determining the caecal index, endotoxin 98 
levels and the expression of tight-junction proteins. The different Lactobacillus species (L. 99 
plantarum, L. casei and L. rhamnosus) were compared to investigate their impact on the 100 
restoration of microbiota in an ampicillin-induced dysbiotic state. The metabolic composition 101 
of faecal water was measured using 1H NMR, and the relationship between the microbial 102 
community and SCFA was correlated to characterise the function of Lactobacillus strains 103 
tested. Our findings provide a novel insight that the administration of different Lactobacillus 104 
strains after ampicillin-induced dysbiosis exhibited distinct effects in modulation of the 105 
microbial community, metabolites and the immune system. 106 
 107 
2 Materials and Methods 108 
2.1 Culturing of bacteria 109 
L. plantarum CGMCC12436 and L. casei CGMCC12435 were isolated from a traditional 110 
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fermented cream from Inner Mongolia, China, and the L. rhamnosus strain GG (LGG) (ATCC 111 
533103) was purchased from ATCC. All strains were held in long-term storage (-80°C in 30% 112 
sterile glycerol) in the Culture Collection of the Food Microbiology (CCFM) of Jiangnan 113 
University. These three strains were cultured in de Man Rogosa and Sharpe (MRS) broth at 114 
37°C overnight. The bacterial cultures were centrifuged and the pellets were resuspended in 115 
0.9% saline solution to give a final concentration of ~1 × 109 CFU per 0.2 mL respectively. 116 
2.2 Experimental animals and ethics statement 117 
The experiments were carried out with four-week-old male C57BL/6 mice obtained from 118 
Slack Experimental Animal Co., LTD (Shanghai, China). Mice were caged in groups of two 119 
or three. Throughout the experiments, distilled water and standard laboratory chow were 120 
provided ad libitum. Light conditions (12 h light/dark cycle), temperature (21°C) and air 121 
humidity were tightly controlled. The experimental procedures and numbers of animals used 122 
were approved by the Ethics Committee of Jiangnan University in China (JN No. 123 
20160608-20160831/47). The experiments were designed in order that both the number of 124 
animals used and their suffering were minimised. 125 
2.3 Experimental groups, timelines and treatment 126 
Mice were allocated to one of six groups (Table 1) and acclimatised for 1 week. 127 
Ampicillin (Sigma, USA) was dissolved in 0.9% saline solution (500 mg kg-1), and mice were 128 
treated via oral gavage with ampicillin for 2 weeks, except for the control group (Con, 129 
n=20-24) which were treated with 0.9% saline solution for 2 weeks. After 2 weeks, the group 130 
of dysbiotic mice (Amp) and half the group of control mice were sacrificed, whilst the 131 
remaining control mice received saline via oral gavage for another 4 weeks; the natural 132 
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restoration group (NaR) pre-treated with ampicillin received saline via oral gavage for 4 133 
weeks; dysbiotic mice were treated via oral gavage with L. rhamnosus GG (LacG group), L. 134 
plantarum CGMCC12436 (LacP group), or L. casei CGMCC12435 (LacC group) respectively, 135 
for 4 weeks. 136 
2.4 Quantification of gut permeability in the serum 137 
The concentrations of endotoxin (ET) and diamine oxidase (DAO) were determined in 138 
serum samples using Enzyme-Linked Immunosorbent Assay (ELISA) kits (SenBeiJia 139 
Biological Technology Co. Ltd., Nanjing, China). Gut permeability was also measured using 140 
4000 Da fluorescent dextran–FITC (DX-4000–FITC) (Sigma-Aldrich, USA) as described in 141 
the supplementary methods. 142 
2.5 Microbiome analysis 143 
Total genomic DNA was extracted from thawed faecal samples with the FastDNA Spin 144 
Kit for Soil (MP Biomedical, USA) according to the manufacturer’s instructions. 145 
Subsequently, the 16S rRNA gene was amplified by PCR with a forward (5’- CCT AYG GGR 146 
BGC ASC AG -3’) and reverse (5’- GGA CTA CNN GGG TAT CTA AT -3’) barcoded primer 147 
set, targeting the V3-V4 region. PCR products were gel-purified and the amplicon DNA 148 
concentration was determined, the libraries were prepared using the TruSeq DNA LT Sample 149 
Preparation Kit (Illumina, USA) and sequenced on the Illumina MiSeq platform (500 cycles 150 
paired-end). The detailed methods of QIIME and Linear Discriminate Analysis (LDA) with 151 
Effect Size (LEfSe) analyses are described in the supplementary methods. 152 
2.6 Faecal metabolomic analysis 153 
Metabolites in the faecal samples of mice were analysed by 1H NMR analysis at 154 
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Quadram Institute Bioscience (United Kingdom). Faecal water was prepared by mixing ~100 155 
mg of frozen faecal samples with 12 times the volume of a phosphate buffer that consisted of 156 
1.9 mM Na2HPO4, 8.1 mM NaH2PO4, 150 mM NaCl, and 1 mM TSP (sodium 157 
3-(trimethylsilyl)-propionate-d4)) in D2O (deuterium oxide). After homogenising thoroughly 158 
with a pellet pestle motor (Kimble Kontes, USA), samples were centrifuged at 14,000 g for 10 159 
min at 4℃. High resolution 1H NMR spectra were recorded using a Bruker AV 600 160 
spectrometer (Bruker, Rheinstetten, Germany). The spectra were analysed as previously 161 
described and further plotting is listed in the supplementary methods (Le Gall et al., 2011). 162 
2.7 Correlation between taxa abundance and metabolites 163 
To evaluate the relationship between the most abundant taxa and observed metabolites, a 164 
correlation test was performed, and associated p-values were adjusted for multiple testing in R. 165 
The physeq package was used to obtain taxa abundance and meta data information, the 166 
ggplot2 package was used to plot figures, “Pearson” was selected as the method to 167 
characterise correlation coefficient, and “adjust meta variables (panel on the correlation plot)” 168 
was selected to adjust p-values for multiple comparisons using Benjamin and Hochberg. 169 
2.8 ELISA analysis of inflammatory cytokines in the colon 170 
Colon tissues (100 mg) were homogenised in 900 μL PBS using a Scientz-50 tissue mill 171 
(Lanzhi, Ningbo, China), centrifuged at 13,000 g for 10 min at 4℃, and the supernatants were 172 
transferred into sterile tubes. The levels of secretory immunoglobulin A (sIgA), nuclear factor 173 
kappa-light-chain-enhancer of activated B cells (NF-қB), monocyte chemotactic protein 1 174 
(MCP-1), interferon-γ (IFN-γ), regenerating islet derived protein 3 gamma (Reg3γ) and 175 
interleukin 1β（ IL-1β）  were determined using respective ELISA kits following the 176 
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10 
manufacturer’s protocols (Nanjing SenBeiJia Biological Technology Co. Ltd. China). 177 
2.9 Immunofluorescence 178 
Colon tissue sections from different groups of mice were fixed by 4% paraformaldehyde 179 
in 0.1 M phosphate buffer. The tissues were excised, post fixed for 3 h in the perfusion 180 
fixative, cryoprotected for 72 h in 30% sucrose in 0.1 M phosphate buffer. Transverse sections 181 
(20 μm) were cut and the slides were incubated with primary NF-B p65 rabbit polyclonal 182 
antibody (Thermo Fisher Scientific, USA) (1:200 dilution) for 2 h at 37°C. Following 183 
incubation, sections were washed in PBS and incubated with secondary goat anti-rabbit 184 
antibody (1:100 in PBS) (Jackson Immuno Research, USA) for 1 h in a dark room. The 185 
sections were incubated with 4,6-Diamidino-2-phenylindole dihydrochlorid (DAPI) (Sigma 186 
Aldrich), washed twice, and visualised under a Leica fluorescence microscope. All 187 
micrographs were taken with identical exposure times and focused on the centre of each well. 188 
2.10 Statistical analysis 189 
Data were represented as mean ± standard error of the mean (SEM). The gut permeability 190 
data were analysed using one-way ANOVA, followed by Dunnett’s multiple comparisons test 191 
in GraphPad Prism 5. The mRNA expression of tight-junction proteins, metabolites and levels 192 
of cytokines were calculated using one-way ANOVA followed by Tukey’s multiple 193 
comparisons test in GraphPad Prism 5. P < 0.05 was considered statistically significant. 194 
2.11 Data deposition 195 
The raw sequence data have been deposited in the NCBI Sequence Read Archive 196 
(Accession no. SRP146081 and BioProject Accession no. PRJNA471394). 197 
 198 
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3 Results 199 
3.1 Effects of Lactobacillus strains on intestinal injury in antibiotic-induced dysbiotic mice 200 
Gut permeability and the caecal index were investigated as indicators of alteration to 201 
intestinal integrity. The Amp mice showed significantly increased levels of DX-4000-FITC in 202 
serum and caecal index, which indicated an increase in gut permeability and an enlargement 203 
of the caecum after antibiotic use compared to the Con group (p < 0.0001, Fig. 1A and B). 204 
The endotoxin concentration was increased (p < 0.0001, Fig. 1C) and the enzyme activity of 205 
serum DAO was decreased in the Amp group compared to the Con group (p < 0.01, Fig. 1D), 206 
demonstrating the damage of mucosal integrity after antibiotic exposure. After four-weeks 207 
restoration, no difference was observed among these four intestinal integrity biomarkers in the 208 
natural restoration group (NaR) compared to controls. Treatment with LacC markedly reduced 209 
the level of DX-4000-FITC and caecal index, and proved to be more effective than LacG and 210 
LacP (Fig. 1A and B). In addition, all groups of Lactobacillus treatment modified the levels of 211 
endotoxin and DAO towards the control level (Fig. 1C and D). 212 
3.2 Effects of Lactobacillus strains on intestinal barrier disruption in antibiotic-induced 213 
dysbiotic mice 214 
To evaluate potential effects of Lactobacillus treatment on paracellular communications 215 
in the intestines, we measured mRNA expression of the tight-junction proteins ZO-1, 216 
Occludin and Claudin-1 in the colon and ileum (Fig. 2). In the colon, the expression of ZO-1 217 
and Occludin were not statistically affected by ampicillin-induced dysbiosis, however, 218 
expression of Claudin-1 was significantly decreased (p < 0.001) after antibiotic use. In the 219 
ileum, levels of all tight-junction proteins were remarkably reduced by ampicillin use (p < 220 
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0.01, p < 0.0001 and p < 0.001 respectively). LacC treatment enhanced the expression of 221 
ZO-1 and Occludin to the control level in the ileum which was more effective than LacG (p < 222 
0.05 and p < 0.001 respectively), while LacP promoted the expression of Claudin-1 in the 223 
ileum to the control level. These data demonstrated that, with regards to the expression of 224 
tight-junction proteins, the disruption by ampicillin and the enhancement by Lactobacillus 225 
strains mainly occurred in the ileum, and the LacC strain showed a promotion of ZO-1 and 226 
Occludin while the LacP strain positively affected Claudin-1 levels. 227 
3.3 Ampicillin-induced colonic microbiome disruption can be largely restored by 228 
Lactobacillus administration 229 
Microbial species richness was indicated by the inverse of the classical Simpson diversity 230 
(Invsimpson Index) as shown in Fig. 3A, which was calculated to eliminate the sampling 231 
effects of the Shannon Index. The bacterial diversity was greatly reduced by ampicillin 232 
treatment (p < 0.001), and three groups of the administration of single Lactobacillus strain 233 
enhanced the level of alpha-diversity to that of the Con group, which was higher than that 234 
observed in the NaR group (p < 0.001). Principal coordinate analysis (PCoA) based on 235 
Phyloseq’s Weighted Unifrac showed that ampicillin-treated mice had a considerably altered 236 
(clustering by distance) microbial community compared to that of the Con mice (Fig. 3B and 237 
C). The profiles of the microbial composition of the Con group and Lactobacillus-restored 238 
groups were clustered more closely to each other than that of naturally-restored mice (Fig. 3B 239 
and C), indicating that tested Lactobacillus strains could restore the antibiotic-treated 240 
microbiota structure towards the normal profile. 241 
Ampicillin treatment led to an increase in Proteobacteria and a severe depletion of 242 
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Bacteroidetes and Verrucomicrobia at the phylum level (Fig. 3D). Natural restoration did not 243 
lead to the recovery of Bacteroidetes, while LacC, LacG and LacP groups had an increase in 244 
the abundance of Bacteroidetes towards, or above (LacC), that of the Con group. Although the 245 
microbiota was not completely restored, the abundance of Proteobacteria was improved to 246 
the control level by LacC and LacP strains, but not by the LacG strain. 247 
We further examined compositional changes of the microbiome at the family or genus 248 
level using high-throughput amplicon sequencing. Following antibiotic cessation, taxa 249 
including Enterobacteriaceae, Klebsiella and Enterococcus were dramatically increased in 250 
Amp mice compared to the Con mice, whereas Akkermansia, Lachnospiraceae and Dorea 251 
were absent in the Amp group (Fig. S1). The cluster of the NaR grouped closer to the Amp 252 
group rather than the Con group, indicating that natural restoration for four weeks after 253 
ampicillin disruption was not effective in recovering the microbial community to the normal 254 
level (Fig. S2). An evaluation of relative abundance (Fig. S4) indicated that Coprobacillus, 255 
S24-7 and Eubacterium were enhanced in the LacC, LacG and LacP groups after 256 
ampicillin-induced depletion, whilst there was no observed restoration in the NaR group. 257 
Meanwhile, the relative abundance of Klebsiella and Enterococcus was reduced by LacC, 258 
LacG and LacP strains after their increase due to ampicillin exposure. These data indicated 259 
that each of the three Lactobacillus strains altered the community structure of the gut 260 
microbiota in a manner different from the ampicillin-induced dysbiotic state towards that of 261 
the Con group. Furthermore, the LEfSe analysis revealed that the number of significantly 262 
altered taxa was lower in LacC (15) than NaR (25) (Fig. 4A and B). The significantly altered 263 
taxa after administration of LacG or LacP was 15 and 13 respectively (Fig. S3), demonstrating 264 
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that restoration of the microbiota by Lactobacillus strains enabled a stronger shift towards the 265 
initial state than observed by natural restoration. 266 
3.4 The LacC strain restored the faecal metabolome following alteration by 267 
ampicillin-induced dysbiosis 268 
The impact of ampicillin-induced microbial community alterations on the faecal 269 
metabolite profiles was evaluated by 1H NMR spectroscopy, which revealed that ampicillin 270 
exposure altered the faecal metabolome composition as can be seen by the clear separation 271 
between the Amp group and the Con group (Fig. 5A). The LacC group clustered closer to the 272 
Con group than the LacG or LacP groups, with NaR positioned between the Con and Amp 273 
groups, indicating that LacC was more effective in restoration of the faecal metabolome than 274 
natural recovery or LacG and LacP strains. Some metabolites, such as amino acids and 275 
carbohydrates produced by the colonic microbiota, were found to have decreased in the faecal 276 
samples of ampicillin-treated mice (Fig. S5). In particular, the SCFA reflected by acetate, 277 
propionate and butyrate were significantly decreased or diminished (p < 0.0001) by the 278 
antibiotic use (Fig. 5B). 279 
The administration of Lactobacillus strains could partly restore the SCFA profile, 280 
however, strain-dependent differences were observed. Acetate, propionate and butyrate levels 281 
were found to be significantly enhanced in the LacC group compared to the Amp group (p < 282 
0.0001, Fig. 5B), increasing towards the same levels as seen in the Con group. The LacG 283 
group increased the levels of acetate and propionate to levels higher than the NaR group, but 284 
had less effect in the recovery of butyrate levels. However, SCFA levels were not significantly 285 
altered in the LacP group. In addition, the increases in lactate levels observed following 286 
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ampicillin administration were significantly reduced by all three Lactobacillus groups and the 287 
NaR group (p < 0.0001, Fig. 5B). Taken together, these results showed that the LacC strain 288 
mitigated the decrease of SCFA in ampicillin-treated mice and was more effective in the 289 
restoring the whole metabolic profile. 290 
3.5 The relationship between altered faecal metabolome and changes in the microbial 291 
community 292 
To assess microbiota-metabolome associations, the functional correlation between 293 
alterations in microbial taxa and metabolites was assessed using Pearson’s correlation 294 
coefficient method, based on 60 bacterial taxa and 8 acids that potentially contributed to the 295 
observed differences between the Amp and Con groups (Fig. 5C). Acetate, butyrate and 296 
succinate were highly correlated with alterations in proportions of bacterial taxa following 297 
ampicillin use. The decrease in acetate within the Amp group was positively correlated with 298 
the decreased relative abundance of Staphylococcus, Streptophyta and Planococcaceae (p < 299 
0.01). The decreased level of butyrate was positively correlated with changes in the relative 300 
abundance of Rikenellaceae, Helicobacter, Lactobacillus, Lactobacillaceae, and 301 
Epulopiscium whilst was negatively correlated with Morganella, Enterobacter and 302 
Enterobacteriaceae in the Amp group. In particular, the enhanced level of acetate in the LacC 303 
group was positively correlated with an increase in the relative abundance of Citrobacter, 304 
Bifidobacterium, Eubacterium, S24-7, Rikenellaceae and Clostridiaceae (p < 0.05, Fig. 5D), 305 
and was negatively correlated with members of Ruminococcus, Ruminococcaceae, Dorea, 306 
Coprococcus, Bilophila, Lachnospiraceae and Desulfovibrionaceae (p < 0.05, Fig. 5D). 307 
However, no significant correlations were observed between microbial taxa and butyrate in 308 
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either the LacC group or LacP (Fig. 5D, E). 309 
3.6 Lactobacillus strains modulated NF-B signalling and colonic inflammation caused by 310 
ampicillin-induced dysbiosis 311 
The serum endotoxin in ampicillin-treated mice was significantly increased (p < 0.0001, 312 
Fig. 1C) compared to the Con mice, indicating that LPS-stimulated TLR4 and NF-B 313 
expression might be induced following ampicillin exposure. NF-B levels determined by 314 
ELISA (Fig. 6B) were significantly increased (p < 0.0001) after ampicillin treatment, and 315 
reduced to control levels by the administration of LacC or LacP. Consistent with the ELISA 316 
results of NF-B, ampicillin treatment increased the level of NF-B p65 (Fig. 6A), and all the 317 
tested Lactobacillus strains could partly reduce the level of p65 compared to that achieved by 318 
natural restoration. Also, due to the positive feedback activation of the NF-B signal pathway, 319 
the level of IL-1β was significantly increased by ampicillin treatment (p < 0.0001), and 320 
reduced by LacC to the level of the Con group (Fig. 6B). Therefore, the LacC strain seemed 321 
to protect against ampicillin-induced inflammatory responses through the regulation of NF-κB 322 
expression in the colon. 323 
To investigate whether disturbance of the microbiota induced alterations in mouse 324 
intestinal immune homeostasis, the local expression levels of several inflammatory mediators 325 
were measured in the colon. In addition, the effects of different Lactobacillus strains against 326 
inflammatory mediator expression were also evaluated. Levels of secretory IgA (sIgA) were 327 
significantly increased in antibiotic-induced mice (p < 0.0001) whilst LacG and LacC reduced 328 
the levels of sIgA to that of the Con group. In ampicillin-treated mice, the expression of 329 
Reg3γ was increased in the colon, and decreased in the LacG group compared to the NaR 330 
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group (p < 0.0001, Fig. 6B). 331 
The inflammatory cytokines including IFN-γ and MCP-1 were also examined to evaluate 332 
colonic inflammation. Levels of IFN-γ and MCP-1 were considerably increased in the Amp 333 
group compared to the Con group (p < 0.0001). IFN-γ was modulated towards the level 334 
observed in the Con group by the LacC group but none of the Lactobacillus groups could 335 
reverse MCP-1 to the same level as the Con group. Taken together, inflammatory mediators 336 
were activated in the colon following treatment with ampicillin, and the LacC strain was more 337 
effective in modulating the levels of sIgA, Reg3γ and IFN-γ whilst LacG administration 338 
reduced the level of Reg3γ. 339 
 340 
4 Discussion 341 
By generating ampicillin-induced dysbiosis in the gut microbiota and related metabolome, 342 
we could analyse the chronic effects of ampicillin on the host and investigate restoration 343 
strategies (Scott et al., 2016). Previous studies applied mouse models to explore the 344 
relationship between antibiotic treatment and subsequent changes in host physiology and gut 345 
microbiota composition (Aguilera et al., 2015; Bech-Nielsen et al., 2012; Mahana et al., 2016; 346 
van Opstal et al., 2016). Although some informative alterations can be measured by 347 
examining the microbiota or the metabolome alone, correlation analyses were employed in 348 
this study to assess the relationship between the microbiota and metabolome and provide 349 
functional information. Furthermore, by comparing the effects of the three Lactobacillus 350 
strains tested here, the present study revealed substantial evidence of associations between 351 
microbial taxa and metabolites in the ampicillin-induced and Lactobacillus-restored mice. 352 
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The Amp mice exhibited a decreased microbial diversity. A reduction in microbial 353 
diversity is associated with multiple gastrointestinal diseases (Guarner, 2015; Le Chatelier et 354 
al., 2013). Several microbial taxa including Enterobacteriaceae, Clostridia, Erwinia, and 355 
Klebsiella were found to be enhanced in the NaR mice (after ampicillin treatment). Among 356 
these changed taxa, the high frequency of Klebsiella and Enterobacteriaceae has been 357 
observed in patients with gastroenteritis and irritable bowel syndrome (Ganji et al., 2016). In 358 
the Amp mice, the increased relative abundance of Enterobacteriaceae and decreased 359 
Lachnospiraceae were strongly associated with gut inflammation. The reduction of Klebsiella 360 
and Enterococcus and the enhancement of Coprobacillus, Bacteroidales and Eubacterium in 361 
all three Lactobacillus treatment groups suggested that Lactobacillus administration 362 
contributed to the promotion of a stable gut microbial community. In particular, the relative 363 
abundance of S24-7 (family) was enhanced in the LacC group and these butyrate-producing 364 
bacteria are beneficial to intestinal epithelial cell health (Villanueva-Millan, Perez-Matute, & 365 
Oteo, 2015). The decrease of the SCFA was not only associated with perturbation of the 366 
microbial communities but also related to the integrity of mucosal barrier in the Amp group. 367 
SCFA are reported to be associated with maintenance of intestinal barrier function; acetate 368 
was shown to be crucial in the inhibition of enteropathogens (Fukuda et al., 2011), and 369 
butyrate production could lead to increased mucin production and promotion of tight-junction 370 
integrity (Jung, Park, Jeon, & Han, 2015). The majority of gut butyrate-producers including 371 
Faecalibacterium, Eubacterium, and Roseburia utilise pathway in which butyryl-CoA is 372 
converted to butyrate (Louis, Young, Holtrop, & Flint, 2010). In this study, following an 373 
initial decrease due to ampicillin exposure, the abundance of Eubacterium improved in each 374 
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of the Lactobacillus administration groups, which may explain the increase of butyrate 375 
observed in these groups. 376 
The correlation between microbial communities and faecal metabolites provided crucial 377 
evidence on the function of bacteria, with alterations at the microbiota-level leading to a 378 
changed metabolome, which could potentially influence gut disease (Claesson et al., 2012; 379 
Tremaroli & Bäckhed, 2012). We observed a positive correlation between the relative 380 
abundance of S24-7 (belong to Bacteroidales) and levels of faecal acetate and butyrate. It was 381 
previously reported that consumption of common bean and chickpea reduced 382 
colitis-associated inflammation, whilst promoting the levels of SCFA and S24-7 (Power et al., 383 
2016). After the administration of the LacC strain, acetate levels were significantly enhanced, 384 
and this increase was positively correlated with the relative abundance of Citrobacter, 385 
Bifidobacterium, Eubacterium and Rikenellaceae in this study. Among these acetate-related 386 
gut bacteria, the selective increase of Bifidobacterium has been shown to protect against 387 
enteropathogenic infection through the enhancement of acetate (Fukuda et al., 2011); in an 388 
elderly health study, genera including Eubacterium were associated with long-stay subjects 389 
and acetate production, as well as gene counts for acetate-producing enzymes, were 390 
significantly higher in long-stay subjects (Claesson et al., 2012). Interestingly, the increased 391 
abundance of Rikenellaceae, which was associated with the increase of acetate in the LacC 392 
group, had previously been associated with potentially beneficial effects on gut health. The 393 
decrease in Rikenellaceae observed in the Amp and NaR groups had recently been observed 394 
in the intestinal dysbiosis of spondyloarthritis (Lin et al., 2014). These analyses of the 395 
functional relationship between microbial taxa and SCFA further specified the possible 396 
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mechanism of functional restoration of LacC strain in the metabolome and microbiome. 397 
Exposure to ampicillin increases levels of endotoxin, activation of the NF-B pathway 398 
and upregulation of the pro-inflammatory cytokines, which are in accordance with the 399 
observations during LPS exposure (Lawrence, 2009). The SCFA-driven inhibition of histone 400 
deacetylases (HDACs) tends to improve an anti-inflammatory cell phenotype that is critical 401 
for maintaining immune homeostasis. A number of studies identified the inactivation of 402 
NF-B and downregulation of pro-inflammatory cytokines by SCFA (Usami et al., 2008; 403 
Vinolo et al., 2011). Also, LPS-induced expression of pro-inflammatory cytokines was 404 
attenuated by Lactobacillus jensenii through the down-regulation of the TLR4-dependent 405 
NF-κB pathway and the mitogen-activated protein kinase (MAPK) in a porcine intestinal 406 
epithelial cell line (Shimazu et al., 2012). In this study, L. casei (LacC), L. plantarum (LacP) 407 
and L. rhamnosus GG (LacG) were administrated to ampicillin-treated mice and the levels of 408 
NF-κB and IL-1β were found to be reduced in the colon by LacC. Collectively, these results 409 
confirm that LacC treatment could modulate the host immune responses through the 410 
TLR4-dependent NF-κB pathway in ampicillin-induced mice, although as yet it is unclear 411 
whether this was through the action of SCFA or a beneficial modulation of the microbiome 412 
structure. 413 
 414 
5 Conclusions 415 
We demonstrated that the three strains of different Lactobacillus species are able to 416 
individually restore antibiotic-induced alterations of the microbiome and the metabolic profile 417 
in mice. We found significant differential changes in colonic microbial taxa and clades by 418 
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LEfSe analysis through the comparison of three Lactobacillus-restored groups with a natural 419 
restoration group. Correlation analysis of associations between the microbiota and 420 
metabolome indicated that LacC strain can promote specific bacterial taxa and SCFA to 421 
attenuate ampicillin-induced dysbiosis, suggesting strain-specific effects on functionally 422 
relevant gut disease. Furthermore, we confirmed that LacC reduced inflammatory activity by 423 
regulating the NF-κB pathway and pro-inflammatory cytokines in ampicillin-induced 424 
dysbiotic mice. These strain-specific Lactobacillus treatments offer the potential to mediate 425 
antibiotic-associated gastrointestinal disturbances and diseases, although clinical trials would 426 
be necessary to confirm their potential beneficial effects in humans. 427 
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Figure Legends 609 
Fig. 1. Effects of Lactobacillus strains administration after antibiotic disturbance on gut 610 
injury. A. Level of DX-4000-FITC measured by ELISA in serum samples from different mice 611 
groups. B. Caecal indexes weighted and calculated through caecum tissues from different 612 
groups. C. Endotoxin and D. DAO concentrations measured by ELISA in serum samples from 613 
all mice groups. 614 
Mice of the Ampicillin group (Amp) were treated with ampicillin for 2 weeks, mice of the 615 
control group (Con) were treated with saline for 2 weeks or 6 weeks; the natural restoration 616 
group (NaR) pre-treated with ampicillin (2 weeks) received saline for another 4 weeks, and 617 
dysbiotic mice, through pre-treatment with ampicillin for 2 weeks were treated with either 618 
Lactobacillus rhamnosus GG (LacG group), L. plantarum CGMCC12436 (LacP group), or L. 619 
casei CGMCC12435 (LacC group) respectively, for 4 weeks. These group names were used 620 
throughout this research paper. One-way ANOVA followed by Dunnett’s multiple 621 
comparisons test was used to determine statistical significance, and the p value was obtained 622 
by comparing the mean of each group with the mean of the Con group, ns means no 623 
significant difference, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Values are 624 
represented as mean ± SEM of 5-8 mice per group. 625 
Fig. 2. The alleviation of intestinal barrier disruption by Lactobacillus treatment. 626 
Real-time PCR analysis of ZO-1, Occludin and Claudin-1 mRNA expression normalised to 627 
β-actin in the colons and ileums of mice from Con, Amp, NaR, LacG, LacC and LacP groups. 628 
One-way ANOVA followed by Tukey’s multiple comparisons test was used to determine 629 
statistical significance, and the p value was obtained by comparing the mean of each group 630 
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with the mean of the Con group, ns means no significant difference, *p < 0.05, **p < 0.01, 631 
***p < 0.001. Values are represented as mean ± SEM of 5-8 mice per group. 632 
Fig. 3. The restorative effect of Lactobacillus strains following ampicillin-induced 633 
dysbiosis via microbial diversity and bacterial abundance measurements. 634 
A. Microbial α-diversity of faecal samples indicated by Shannon Index, Simpson Index and 635 
Invsimpson Index. The richness of each sample was estimated in a phyloseq data object, and 636 
one-way ANOVA followed by Dunnett’s multiple comparisons test was used to determine 637 
statistical significance, with the p value obtained by comparing the mean of each group with 638 
the mean of the Con group, ns means no significant difference, *p < 0.05, **p < 0.01, ***p < 639 
0.001. 640 
B. Principal coordinates analysis (PCoA) and C. clustering of distance based on Phyloseq’s 641 
Weighted Unifrac to present differences in microbial community structure between samples 642 
from Amp ( ), Con ( ), LacC ( ), LacG ( ), LacP ( ) and NaR ( ) groups. The first 643 
principal component (PC1) and second principal component (PC2) explained 51.6% and 16.2% 644 
of the variance in the Weighted UniFrac metrics, respectively. Each point represents the faecal 645 
microbiome of a single sample. 646 
D. The abundance of bacterial phyla in faecal samples from Amp, Con, LacC, LacG, LacP 647 
and NaR mice groups. The rectangles representing Bacteroidetes, Firmicutes, Proteobacteria, 648 
Tenericutes and Verrucomicrobia were stacked in order and the aggregate height of the 649 
stacked bar reflects the quantitative information. 650 
Fig. 4. Comparison of differential microbial communities from mice groups using LEfSe. 651 
A. Circular cladogram of biologically and statistically consistent differences in faecal 652 
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microbial clades between NaR and Con groups. In the panel, each circle’s diameter was 653 
proportional to the taxon’s abundance, green = taxon significantly enriched in NaR, red = 654 
taxon significantly enriched in Con and yellow = non-significant. The cladogram 655 
simultaneously highlights specific genera/families and high-level trends. 656 
B. Histogram of LDA scores computed for taxa that have differential abundance in NaR and 657 
Con groups of mice. The magnitude of the LEfSe scores represents the degree of difference in 658 
relative abundance between features in the NaR and Con groups. 659 
C. Circular cladogram of biologically and statistically consistent differences in faecal 660 
microbial clades between LacC and Con groups. Green = taxon significantly enriched in LacC, 661 
red = taxon significantly enriched in Con and yellow = non-significant. The cladogram 662 
simultaneously highlights specific genera/families and high-level trends. 663 
D. Histogram of LDA scores computed for taxa that have differential abundance in LacC and 664 
Con groups of mice. The magnitude of the LEfSe scores represents the degree of consistent 665 
difference in relative abundance between features in the LacC and Con groups. 666 
Fig. 5. The restoration effect of selected Lactobacillus strains after ampicillin-induced 667 
dysbiosis based on metabolomic analyses and the correlation between taxa abundance 668 
and metabolite alterations. 669 
A. Principal component plot analysis of faecal metabolites altered in the Amp ( ), Con ( ), 670 
LacC ( ), LacG ( ), LacP ( ) and NaR ( ) groups. The first principal component (PC1) 671 
and second principal component (PC2) explained 36.8% and 17.6% of the variance 672 
respectively. Each point represents the faecal metabolites in a single sample. 673 
B. Distribution of intensities for the selected four acids based on the metabolomic analysis. 674 
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Each point represents the faecal metabolites in a single sample, and the mean and SEM were 675 
indicated by horizontal lines. One-way ANOVA followed by Tukey’s multiple comparisons 676 
test was used to determine statistical significance, and the p value was obtained by comparing 677 
the mean of each group with the mean of the Con group, ns means no significant difference, 678 
*p < 0.05, ***p < 0.001, ****p < 0.0001. 679 
C. Correlation analysis of microbial taxa and acids, as quantified using NMR intensity, 680 
between the Con and Amp groups. Top 60 microbial taxa and metabolites in the correlation 681 
matrix were filtered prior to the Pearson’s correlation coefficient method being applied. 682 
Significant microbiota-metabolite correlations were determined based on adjusted p-values 683 
for multiple comparisons using Benjamin and Hochberg, *p < 0.05, **p < 0.01, ***p < 0.001. 684 
Positive correlations between taxa and acids were presented in red, and negative correlations 685 
were presented in blue. 686 
Correlation plot of top 27 taxa associated with acetate or butyrate in the Con and LacC groups 687 
(D), or Con and LacP groups (E). Pearson’s correlation coefficient method was applied and 688 
significant microbiota-metabolite correlations were determined based on adjusted p-values for 689 
multiple comparisons, *p < 0.05, **p < 0.01, ***p < 0.001. Positive correlations between taxa 690 
and acids were presented in red, and negative correlations were presented in blue. 691 
Fig. 6. Effects of ampicillin and subsequent administration of Lactobacillus strains on 692 
immune and host-bacterial interaction markers. 693 
A. Immunofluorescence analysis of NF-B p65 in the colons of mice from Con, Amp, NaR, 694 
LacG, LacC and LacP groups. The expression of p65 (green light) and DAPI (blue light) was 695 
observed under the same exposure times (Representative images, n =4/group). 696 
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B. ELISA analysis of levels of sIgA, NF-B, Reg-3γ, IFN-γ, MCP-1 and IL-10 in the colons 697 
of mice from Con, Amp, NaR, LacG, LacC and LacP groups. One-way ANOVA followed by 698 
Tukey’s multiple comparisons test was used to determine statistical significance, and the p 699 
value was obtained by comparing the mean of each group with the mean of the Con group, ns 700 
means no significant difference, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Values 701 
are represented as mean ± SEM of 5-8 mice per group.  702 
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Table 1. Animal experimental design 703 
Groups Antibiotic treatment  
(2 weeks) 
Lactobacillus therapy assay 
(4 weeks) 
Control (Con) 0.9% saline solution 0.9% saline solution or sacrifice 
Ampicillin (Amp) Ampicillin (500 mg kg-1) Sacrifice 
Natural Restoration (NaR) Ampicillin (500 mg kg-1) 0.9% saline solution 
L. rhamnosus GG (LacG) Ampicillin (500 mg kg-1) LacG 109 CFU in 0.9% saline 
L. casei CGMCC 12435 (LacC) Ampicillin (500 mg kg-1) LacC 109 CFU in 0.9% saline 
L. plantarum CGMCC12436 (LacP) Ampicillin (500 mg kg-1) LacP 109 CFU in 0.9% saline 
 704 
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